COVID-19 has disproportionately affected Blacks, Latinos, Asian Americans and those over 65, who, traditionally, have been less likely to be included in clinical trials.
The Oregon Health Authority is tracking active outbreaks in at least 30 of what the state calls “congregate care facilities,” while outbreaks at another 38 of these locations have been resolved.